Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHC.L Regulatory News (PHC)

  • There is currently no data for PHC

Board Appointment

2 Feb 2009 11:01

RNS Number : 6266M
Plant Health Care PLC
02 February 2009
 



02 February 2009

Plant Health Care plc

("Plant Health Care" or "the Company")

NEW BOARD APPOINTMENT

Plant Health Care (AIM: PHC.L), a leading provider of natural products to the agriculture and landscape industries, announces that Dr. Dominik Koechlin was appointed to its Board as a non-executive director on 30 January 2009.

Dr. Koechlin, 50, a Swiss national, graduated from the University of Berne with a doctorate in law. He also has an MBA from INSEAD, Fontainebleau, France. Dr. Koechlin is currently a non-executive director of LGT Bank in Liechtenstein, and the following Swiss-listed companies: EGL AG, Swissmetal AG and Clariant AG.

Dr. Koechlin began his career working at Bank Sarasin in Basel from 1986 to 1988. He founded Ellipson AG in 1990, a business and management consultancy specialised in environmentally sound management and corporate financing. From 1996, he was a member of the executive committee of Telecom PTT and Swisscom AG.

During his time at Swisscom, the leading telecommunications provider in Switzerland, Dr. Koechlin was responsible for the redesign of the Swisscom business model, preparation for the IPO of Swisscom and development and communication of corporate strategy, as well as the international participations of Swisscom. Since 2001, Dr. Koechlin has worked as an independent board member and consultant for a number of listed and private businesses.

Dr. Albert Fischer, Non-executive Chairman of Plant Health Care commented:: "Dr. Koechlin has a great deal of experience in advising profitable, high-growth listed companies and will be a very strong addition to the Plant Health Care Board."

There is no other information that is required to be disclosed pursuant to Schedule 2 paragraph (g) of the AIM Rules, save as set out below:

Dominik Koechlin

Current Directorships

Past Directorships within last 5 years

LGT Bank in Liechtenstein Limited

Crucell NV

Elektrizitäts-Gesellschaft Laufenburg AG

Sustainable Asset Management AG

Swissmetal AG

Berna Biotech AG

Clariant AG

Novavox AG

Avaloq AG

Hesperion AG

M2 AG

Corris AG

- ends -

For further information:

John Brady

Evolution Securities Limited

Tavistock Communications

Chief Executive

Tim Worlledge/Tim Redfern

Jeremy Carey/Simon Compton

Tel: 001 603 525 3702

Tel: 020 7071 4300

Tel: 020 7920 3150

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAILFEIFAIFIIA
Date   Source Headline
20th Apr 20227:00 amRNSHolding(s) in Company
19th Apr 20221:46 pmRNSNotice of results and investor presentation
11th Apr 202212:52 pmRNSHolding(s) in Company
1st Apr 20227:00 amRNSNew Distribution agreement with Ager Agro
14th Mar 202212:49 pmRNSHolding(s) in Company
11th Mar 202212:19 pmRNSHolding(s) in Company
3rd Feb 202212:56 pmRNSHolding(s) in Company
1st Feb 20221:16 pmEQSPlant Health Care, plc
1st Feb 20227:00 amRNS2021 Trading Statement
31st Jan 20227:00 amRNSPHC949 product registration submitted to the EPA
17th Jan 20227:00 amRNSInvestor Presentation
15th Dec 20217:00 amRNSWilbur Ellis and Plant Health Care discussion
13th Dec 20217:00 amRNSCommercial scale manufacturer for Saori
30th Nov 20214:36 pmRNSPrice Monitoring Extension
20th Oct 20216:03 pmRNSExercise of Options
22nd Sep 20217:00 amRNSNew agreement with Nutrien for Saori launch
22nd Sep 20217:00 amRNSInterim Report 30 June 2021
21st Sep 20214:41 pmRNSSecond Price Monitoring Extn
21st Sep 20214:35 pmRNSPrice Monitoring Extension
1st Sep 20217:00 amRNSArgentina approves Harpin as a seed treatment
24th Aug 20217:00 amRNSInvestor Presentation
18th Aug 20214:41 pmRNSSecond Price Monitoring Extn
18th Aug 20214:36 pmRNSPrice Monitoring Extension
9th Aug 20211:27 pmRNSHolding(s) in Company
3rd Aug 20217:00 amRNSAdmission to the U.S. OTCQB Venture Market
27th Jul 20217:00 amRNSNew Distribution Agreement with Agrii UK
26th Jul 20217:00 amRNS2021 Half-Year Trading Statement
23rd Jul 20217:00 amRNSGrant of Options
22nd Jul 20217:00 amRNSInvestor Presentation
12th Jul 20214:40 pmRNSSecond Price Monitoring Extn
12th Jul 20214:35 pmRNSPrice Monitoring Extension
29th Jun 20214:41 pmRNSSecond Price Monitoring Extn
29th Jun 20214:35 pmRNSPrice Monitoring Extension
14th Jun 20212:33 pmRNSResult of AGM
14th Jun 20217:00 amRNSGreen Economy Mark awarded
9th Jun 20214:41 pmRNSSecond Price Monitoring Extn
9th Jun 20214:35 pmRNSPrice Monitoring Extension
20th May 20217:00 amRNSInvestor Presentation
7th May 20213:50 pmRNSAnnual Report & Accounts and AGM Notice Published
30th Apr 20215:40 pmRNSHolding(s) in Company
23rd Apr 20217:00 amRNSResults for the year ended 31 December 2020
21st Apr 202111:58 amRNSHolding(s) in Company
8th Apr 20213:30 pmRNSHolding(s) in Company
1st Apr 20217:00 amRNSTotal Voting Rights
22nd Mar 20217:00 amRNSInvestor Presentation
18th Mar 20211:57 pmRNSResults of Placing and Subscription
18th Mar 20217:00 amRNSProposed Placing and Subscription
1st Mar 20217:00 amRNSSaori Trial Update
3rd Feb 20214:41 pmRNSSecond Price Monitoring Extn
3rd Feb 20214:36 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.